Patent ID: 8859536

Claim:
A compound of Formula (I): wherein R 1 is a bicyclic ring system which contains 9 to 11 ring members including 1 to 4 heteroatoms independently selected from the group consisting of N, O, and S, in which said bicyclic ring system may be substituted by 1 to 3 groups independently selected from the group consisting of C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, halo, hydroxyl, oxo, —C(O)NR c R d , —COOH, —C(O)R a , —SO 2 R a , arylalkyl, —(C 1 -C 3 alkyl)aryloxy, aryl, heteroaryl and C 1 -C 4 alkoxy, in which each R a is independently C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl or unsubstituted C 3 -C 7 cycloalkyl; each R 2 and R 3 is independently hydrogen, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, halo, hydroxyl, —C(O)NR c R d , —COOH or C 1 -C 4 alkoxy; and m is 0-2; wherein any said substituted C 1 -C 6 alkyl is substituted by 1 to 3 groups independently selected from the group consisting of unsubstituted C 3 -C 7 cycloalkyl, methyl, ethyl, propyl, isopropyl, butyl, t-butyl, difluoromethyl, trifluoromethyl, halo, —NR′R″, cyano, hydroxyl, C 1 -C 4 alkoxy, —COOH, —COO(methyl), —COO(ethyl), and —C(O)NR c R d , wherein R′ and R″ are each independently selected from the group consisting of hydrogen, unsubstituted C 1 -C 6 alkyl, —C(O)R b , and unsubstituted C 3 -C 7 cycloalkyl, wherein R b is unsubstituted C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, or heterocyclyl; and wherein each R c and R d are independently hydrogen or C 1 -C 6 alkyl; or a pharmaceutically acceptable salt thereof.